Predicting the molecular subtype of breast cancer based on mammography and ultrasound findings

Abstract

Aim: To determine the correlation between mammography and ultrasound features of breast cancer with molecular subtypes and to calculate the predictive value of these features. Materials and Method: This is a prospective study of consecutive patients with breast cancer presenting between January 2016 and July 2017, who underwent mammography and/or ultrasound of breast and excision of the breast mass. Patients with contralateral breast mass, metastases, h/o prior cancer treatment, and other malignancies were excluded. On mammography, the presence or absence of microcalcification was noted. On ultrasound examination size, margins, microcalcification, posterior acoustic features, vascularity, and axillary nodes were assessed. Margins were categorized into circumscribed and non-circumscribed. Posterior acoustic features were classified into four categories: shadowing, enhancement, mixed, and no changes. Vascularity was assessed based on Adler's index into grades 0, 1, 2, and 3. Grades 0 and 1 were considered low and 2 and 3 were high. Results: Tumors with non-circumscribed margins and posterior acoustic shadowing were likely to be luminal A or B subtype of breast cancer [odds ratio (JR) 5.78; 95% confidence interval (CI) 3.68–9.80; P < 0.0001]. Tumors with non-circumscribed margins, posterior acoustic shadowing, and high vascularity were more likely to be luminal B subtype (JR 2.88; 95% CI 2–4.14; P- <0.0001). Tumors with microcalcification and posterior mixed acoustic pattern were strongly associated to be HER2-positive (JR 5.48; 95% CI 3.06–9.80; P < 0.0001). Tumors with circumscribed margins and posterior acoustic enhancement were highly suggestive of triple-negative breast cancer (JR 7.06; 95% CI 4.64–10.73; P < 0.0001). Conclusion: Microcalcification detected on mammography and certain ultrasound features such as circumscribed or non-circumscribed margins, posterior acoustic features, and vascularity are strongly correlated in predicting the molecular subtypes of breast cancer, and thus may further expand the role of conventional breast imaging.

Keywords

Breast cancer - mammography - microcalcifications - molecular subtype - posterior acoustic features - predicting value - ultrasound - vascularity

Publication History

Article published online:
26 July 2021

• References

• 1 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: 359-86
• 2 Celebi F, Pilanci KN, Ordu C, Agacayak F, Alco G, Ilgun S. et al. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer. Diagn Interv Radiol 2015; 21: 448-53
• 3 Yaganawa M, Ikemot K, Kawauchi S. Luminal A and Luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype. BMC Res Notes 2012; 5: 376
• 4 Huber KE, Carey LA, Wazer DE. Breast cancer molecular subtypes in patients with locally advanced disease: Impact on prognosis, patterns of recurrence, and response to therapy. Semin Radiat Oncol 2009; 19: 204-10
• 5 Lam SW, Jimenez CR, Boven E. Breast cancer classification by proteomic technologies: Current state of knowledge. Cancer Treat Rev 2014; 40: 129-38
• 6 Irshad A, Leddy R, Pisano E, Nathaniel Baker, Madelene Lewis, Susan A. et al Assessing the role of ultrasound in predicting the biological behavior of breast cancer. AJR Am J Roentgenol 2013; 200: 284-90
• 7 Blaichman J, Marcus JC, Alsaadi T, El-Khoury M, Meterissian S, Mesurolle B. et al. Sonographic appearance of ductal carcinoma of the breast according to histologic grade. AJR Am J Roentgenol 2012; 199: W402-8
• 8 Reis-Filho JS, Simpson PT, Gale T, Lakhani SR. The molecular genetics of breast cancer: The contribution of comparative genomic hybridization. Pathol Res Pract 2005; 201: 713-25
• 9 Bosch A, Eroles P, Zaragoza R, Vina JR, Lluch A. Triple negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 2010; 36: 206-15
• 10 Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S. et al. Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology 2008; 246: 367-75
• 11 Cheang MB, Chia SK, Voduc D, Gao D, Leung S, Snider J. et al. Ki67 index, HER2 status, and prognosis of patients with Luminal B breast cancer. J Natl Cancer Inst 2009; 101: 736-50
• 12 Cen D, Xu L, Li N, Chen Z, Wang L, Zhou S. et al. BI-RADS 3-5 microcalcifications can preoperatively predict breast cancer HER2 and Luminal a molecular subtype. Oncotarget 2017; 8: 13855-62
• 13 Zhang L, Li J, Xiao Y, Cui H, Du G, Wang Y. et al. Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision. Sci Rep 2015; 5: 11085
• 14 Anupama T, Prachi S, Smita M, Neelam W, Natasha G, Navneet K. et al. Role of Sonography in predicting the hormone receptor status of breast cancer: A prospective study. J Diagn Med Sonogr 2017; 1: 12
• 15 Boisserie-Lacroix M, Mac Grogan G, Debled M, Ferron S, Asad-Syed M, Brouste V. et al. Radiological features of triple negative breast cancers (about 73 cases). Diagn Interv Imaging 2012; 93: 196-203
• 16 Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y. et al. Correlation of HER-2/ne overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 2006; 13: 1211-8
• 17 Patel TA, Puppala M, Ogunti RO, Ensor JE, He T, Shewale JB. et al. Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods. Cancer 2017; 123: 114-21
• 18 Kojima Y, Tsunoda H. Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer 2011; 18: 146-51